Revised Pharmaceutical Affairs Law In Japan Passed, Commercialization And Safety Measures Expected
This article was originally published in PharmAsia News
Executive Summary
The “Act for Partial Revision of the Pharmaceutical Affairs Law” and the “Act to Ensure the Safety of Regenerative Medicine” were passed at the Upper House plenary session in Japan on Nov. 20.